Filter
1459
Filtered Results: 1459
Text search:
WHO,
Pan
American
Health
Organization
Featured
Recommendations
158
New Publications
245
Language
Document type
No document type
488
Studies & Reports
336
Guidelines
325
Manuals
113
Strategic & Response Plan
70
Fact sheets
41
Training Material
34
Situation Updates
19
Resource Platforms
11
Infographics
11
Brochures
6
Online Courses
3
Dashboards/Maps
1
Videos
1
Countries / Regions
Latin America and the Carribbean
188
Global
105
Brazil
64
Colombia
34
Venezuela
25
Africa
24
Haiti
24
Paraguay
20
India
16
Mozambique
15
North America
15
Angola
12
Argentina
11
Syria
10
Kenya
9
Chile
9
Peru
9
Western and Central Europe
9
Myanmar / Burma
9
Nigeria
8
Guinea-Bissau
8
Middle East and North Africa
8
Russia
8
Nepal
7
Philippines
7
Asia
7
Ethiopia
7
Ukraine
6
West and Central Africa
6
South Africa
6
Yemen
6
Liberia
6
Ecuador
6
Ghana
5
Tanzania
5
Bolivia
5
Bangladesh
5
Uganda
5
Eastern Europe
5
South Sudan
5
Mexico
4
El Salvador
4
Sierra Leone
4
Cambodia
4
East and Southern Africa
4
Honduras
4
Zambia
4
Indonesia
4
Eswatini/ Swaziland
4
Iran
3
Burkina Faso
3
Malawi
3
Dominican Republic
3
Congo, Democratic Republic of
3
Spain
3
Pakistan
3
Guatemala
3
China
2
Rwanda
2
Zimbabwe
2
South–East Asia Region
2
Uruguay
2
Jamaica
2
Papua New Guinea
2
Nicaragua
2
Moldova
2
Sudan
2
Tajikistan
1
Thailand
1
Lesotho
1
Benin
1
Albania
1
Fiji
1
Laos
1
Estonia
1
Kyrgyzstan
1
Morocco
1
Guinea
1
Italy
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Japan
1
France
1
Tunisia
1
Portugal
1
Latvia
1
Belize
1
Costa Rica
1
Guyana
1
Panama
1
Lebanon
1
Vietnam
1
Namibia
1
Greece
1
Georgia
1
Central African Republic
1
Mali
1
Libya
1
Botswana
1
Iraq
1
Somalia
1
Madagascar
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
396
Clinical Guidelines
162
Public Health
112
Key Resources
101
Women & Child Health
83
Capacity Building
25
Pharmacy & Technologies
24
Annual Report MEDBOX
1
Toolboxes
COVID-19
265
Mental Health
126
NTDs
95
HIV
87
TB
72
Planetary Health
68
Zika
51
Caregiver
45
NCDs
45
Rapid Response
40
Malaria
40
Global Health Education
32
Disability
31
AMR
30
Natural Hazards
23
Pharmacy
22
Health Financing Toolbox
21
2.0 Rapid Response
21
Conflict
20
Ebola & Marburg
18
Refugee
15
Cholera
13
Specific Hazards
7
Polio
4
Social Ethics
3
Typhoon
2
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
The document introduces a simple classification, minimums standards and a registration form for Foreign Medical Teams (FMTs) that may provide surgical and trauma care arriving within the aftermath of a sudden onset disaster. These can serve as tools to improve the coordination of the foreign medical...
Rabies is a global public health problem with important socioeconomic impacts. Human rabies is preventable; almost all cases are transmitted through the bite of a rabid dog. Elimination of human rabies is possible. Technical support and tools are available. This report covers:
- Why investment ...
- Why investment ...
Доклад Секретариата по теме Деменция
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
IPCAT2 will assist countries to determine the core components already in place, that is, existing strengths, and to identify gaps or weaknesses to guide action planning. IPCAT2 corresponds to the six core component recommendations of the guidelines targeted at the national level.
It is very impor...
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
The COVID-19 pandemic arrived in an evolving epidemiological context where some countries are experiencing a progressive decrease in HIV positivity in their testing programme as they are moving closer to the first 95 target. Distinguishing changes in HIV testing services due to the COVID-19 pandemic...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
This document is for public health specialists, health emergency responders, clinicians, health facility managers, health and care workers and IPC practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, dental practices, infecti...
Drawing on the World Health Organization’s package of NCD best buys, the report demonstrates how these evidence-based measures can help countries reduce premature deaths, strengthen health systems, and advance progress towards the Sustainable Development Goals. It provides policymakers, donors, ad...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа...
